Skip to content

Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity

Janis Fricke, Alexander M. Sherwood, Adam L. Halberstadt, Robert B. Kargbo, Dirk Hoffmeister

Journal of Natural Products March 5, 2021 DOI: 10.1021/acs.jnatprod.1c00087 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical study Peer reviewed
Population Mice
Intervention 5-methylpsilocybin
Topics Psilocybin
Keywords Tryptamine Biological activity Biochemistry Hallucinogen Stereochemistry In vitro
Citations 18
Key points 5-methylpsilocybin induced psychedelic-like activity in mice that was more potent than dimethyltryptamine but less potent than psilocybin.

Abstract

A novel analogue of psilocybin was produced by hybrid chemoenzymatic synthesis in sufficient quantity to enable bioassay. Utilizing purified 4-hydroxytryptamine kinase from Psilocybe cubensis, chemically synthesized 5-methylpsilocin (2) was enzymatically phosphorylated to provide 5-methylpsilocybin (1). The zwitterionic product was isolated from the enzymatic step with high purity utilizing a solvent-antisolvent precipitation approach. Subsequently, 1 was tested for psychedelic-like activity using the mouse head-twitch response assay, which indicated activity that was more potent than the psychedelic dimethyltryptamine, but less potent than that of psilocybin.

Comparable studies

Other preclinical and animal studies on psilocybin, most cited first.

Citations in the library

Cited by 11

and 6 more in the library

Cites 26

and 21 more in the library

Explore topics